NEK2 and glioblastoma: Obviously, the percentages of early (AV+; PI−) and late (AV+; PI+) cell apoptosis in NEK2 knockdown GBM cells pretreated with TNF-α were significantly reduced when compared with NEK2 knockdown GBM cells (Fig. 5G, H).